Gregory Twachtman
![1]()
News
CMS implements temporary regulatory changes to aid COVID-19 response
March 31, 2020
The regulatory relief includes the ability for ambulatory surgery centers to bill as hospitals and more widespread use of telehealth.
![1]()
News
FDA to allow alternative respiratory devices to treat COVID-19
March 25, 2020
“We are providing maximum regulatory flexibility to facilitate an increase in ventilator inventory.”
![1]()
News
Three COVID-19 rapid diagnostic tests get FDA thumbs-up
March 24, 2020
One of the point-of-care tests can deliver results in 30 minutes, the remaining two, at 45 minutes.
![1]()
News
Feds tout drug candidates to treat COVID-19
March 19, 2020
Food and Drug Administration officials and President Trump highlighted hydroxychloroquine and remdesivir.
![1]()
News
White House expands Medicare telehealth services amid COVID-19
March 17, 2020
Seniors across the nation, no matter where they live, will be able to receive a wide range of services via telehealth.
![1]()
News
FDA provides flexibility to improve COVID-19 test availability
March 17, 2020
Laboratories developing tests who work with the appropriate state authorities will no longer need to pursue an emergency use authorization from the FDA.
![1]()
News
Trump to governors: Don’t wait for feds on medical supplies
March 16, 2020
President Trump outlined new guidance for Americans to avoid gatherings of more than 10 people.
News
President declares national emergency for COVID-19, ramps up testing capability
March 13, 2020
An additional 5 million COVID-19 tests will be available within a month, President Trump announced.
![1]()
News
WHO declares COVID-19 outbreak a pandemic
March 11, 2020
The WHO Director-General cited the “alarming levels of spread and severity” and the “alarming levels of inaction.”
![1]()
News
FDA cancels or postpones meetings amid COVID-19 concerns
March 10, 2020
Thus far, only a few Center for Drug Evaluation and Research events on the FDA's meeting webpage are listed as being canceled or postponed.
